Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
IDRA

Overview Financials Analysis Smart Money

Idera Pharmaceuticals, Inc.

IDRA · NASDAQ

Analyze with AI

Filings1

Total reported value$9.0K

Manager	Shares	Value	Change
Aperio Group, LLC	21.1K	$9.0K	0.0%

SymbolIDRA

Market Cap–

IPO Date1996-01-25

CEOVincent J. Milano

Employees13

SectorHealthcare

IndustryBiotechnology

CountryUS

ExchangeNASDAQ Capital Market

Athira Pharma, Inc.

ATHA

$6.91

+66.99%

Sable Offshore Corp.

SOC

$8.79

+66.48%

urban-gro, Inc.

UGRO

$0.4341

+46.66%

FuelCell Energy, Inc.

FCEL

$10.56

+33.67%

Trump Media & Technology Group Corp.

DJT

$13.90

+32.78%

Peers

AnPac Bio-Medical Science Co., Ltd.

ANPC · NASDAQ

$4.30

-3.15%

LakeShore Biopharma Co., Ltd

LSB · NASDAQ

$0.627

+0.00%

Gemini Therapeutics, Inc.

GMTX · NASDAQ

$1.35

+0.00%

Serina Therapeutics, Inc.

SER · NYSE

$2.85

-3.06%

Liminal BioSciences Inc.

LMNL · NASDAQ

$8.50

+0.12%

Vincerx Pharma, Inc.

VINC · NASDAQ

$0.013

+0.00%

Freeline Therapeutics Holdings plc

FRLN · NASDAQ

$6.49

+0.15%

Marinus Pharmaceuticals, Inc.

MRNS · NASDAQ

$0.55

+0.00%

Allakos Inc.

ALLK · NASDAQ

$0.3291

+0.22%

Angion Biomedica Corp.

ANGN · NASDAQ

$1.00

+0.00%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.